Page 8 - Aptose Biosciences Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptose biosciences company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptose Biosciences Company Profile Today - Breaking & Trending Today

Aptose Biosciences (NASDAQ:APTO) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other research firms also recently weighed in on APTO. Royal Bank of Canada reissued an outperform rating and set a […] ....

Aptose Biosciences , Renaissance Technologies , Royal Bank , Canaccord Genuity Group , Aptose Biosciences Inc , Annandale Capital , Sigma Planning Corp , Aptose Biosciences Company Profile , Get Rating , Genuity Group , Planning Corp , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto , Initiated Coverage , Stocknews Com ,

Aptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) in a research report report published on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Several other analysts also recently issued reports on APTO. Royal Bank of Canada reissued an outperform rating and issued a $5.00 price target […] ....

Dumfries And Galloway , United Kingdom , Aptose Biosciences , Royal Bank , Aptose Biosciences Inc , Millennium Management , Annandale Capital , Renaissance Technologies , Canaccord Genuity Group , Toronto Dominion Bank , Sigma Planning Corp , Aptose Biosciences Company Profile , Get Rating , Genuity Group , Planning Corp , Dominion Bank , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto , Initiated Coverage , Stocknews Com ,

Aptose Biosciences' (APTO) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) in a research report released on Friday, Benzinga reports. They currently have a $5.00 target price on the biotechnology company’s stock. Separately, StockNews.com started coverage on Aptose Biosciences in a research report on Thursday, March 16th. They […] ....

Aptose Biosciences , Sequoia Financial Advisors , Toronto Dominion Bank , Aptose Biosciences Company Profile , Royal Bank , Aptose Biosciences Inc , Renaissance Technologies , Sigma Planning Corp , Voss Capital , Get Rating , Financial Advisors , Dominion Bank , Planning Corp , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto , Reiterated Rating , Royal Bank Of Canada ,

Aptose Biosciences (NASDAQ:APTO) Releases Earnings Results, Meets Estimates

Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.11), Yahoo Finance reports. During the same quarter in the previous year, the company earned ($0.27) EPS. Aptose Biosciences Trading Up 13.0 % NASDAQ:APTO […] ....

Aptose Biosciences , Cetera Advisors , Millennium Management , Renaissance Technologies , Annandale Capital , Aptose Biosciences Inc , Royal Bank , Aptose Biosciences Company Profile , Sequoia Financial Advisors , Get Rating , Yahoo Finance , Financial Advisors , Biosciences Inc , Aptose Biosciences Daily , Nasdaq Apto ,

Aptose Biosciences Inc. Expected to Earn FY2022 Earnings of ($0.60) Per Share (TSE:APS)

Aptose Biosciences Inc. (TSE:APS – Get Rating) (NASDAQ:APTO) – Cantor Fitzgerald issued their FY2022 earnings estimates for Aptose Biosciences in a note issued to investors on Wednesday, September 21st. Cantor Fitzgerald analyst L. Watsek forecasts that the biotechnology company will post earnings per share of ($0.60) for the year. Cantor Fitzgerald currently has a “Overweight” […] ....

Aptose Bioscience , Aptose Biosciences , Aptose Biosciences Company Profile , Cantor Fitzgerald , Aptose Biosciences Inc , Get Rating , Biosciences Inc , Aptose Biosciences Daily , Tse Aps , Earnings Estimates ,